In Stock
Mesalamine Prolonged Release Tablets IP
Mesalamine Prolonged Release Tablets IP is an anti-inflammatory medicine used to manage ulcerative colitis and reduce inflammation in the lining of the intestine.
Product Details
Mesalamine Prolonged Release Tablets IP contains mesalamine, also known as 5-aminosalicylic acid (5-ASA), an intestinal anti-inflammatory medicine used primarily in the management of ulcerative colitis. It works locally in the bowel to reduce inflammation and help control symptoms such as abdominal discomfort and diarrhea.
Key Benefits
- Helps manage mild to moderate ulcerative colitis
- Reduces inflammation in the intestinal lining
- Helps control symptoms such as diarrhea and abdominal discomfort
- May help maintain remission in appropriate patients
- Supports long-term management of inflammatory bowel disease
How It Works
Mesalamine acts locally on the lining of the intestine and helps reduce the production and activity of inflammatory substances. This decreases inflammation in the bowel and helps control symptoms associated with ulcerative colitis.
Common Side Effects
- Headache
- Nausea
- Abdominal pain
- Diarrhea
- Indigestion
- Flatulence
- Dizziness
- Skin rash
Important Information
Mesalamine Prolonged Release Tablets IP should be used under the guidance of a qualified healthcare professional. Kidney and liver function may need to be monitored during treatment, particularly in patients with existing kidney or liver problems. Take the prolonged-release formulation exactly as prescribed and do not alter it unless instructed. Seek medical advice if severe abdominal pain, persistent vomiting, unusual bleeding, rash, fever, or changes in urination occur.
